Aby wyświetlić tę treść, wymagana jest subskrypcja JoVE. Zaloguj się lub rozpocznij bezpłatny okres próbny.

W tym Artykule

  • Podsumowanie
  • Streszczenie
  • Wprowadzenie
  • Protokół
  • Wyniki
  • Dyskusje
  • Ujawnienia
  • Podziękowania
  • Materiały
  • Odniesienia
  • Przedruki i uprawnienia

Podsumowanie

Published data pertaining to calcitonin gene-related peptide (CGRP) concentrations in human plasma are inconsistent. These inconsistencies may be due to the lack of a standardized, validated methodology to quantify this neuropeptide. Here, we describe a validated enzyme-linked immunosorbent assay (ELISA) protocol to purify and quantify CGRP in human plasma.

Streszczenie

Calcitonin gene-related peptide (CGRP) is a vasoactive neuropeptide that plays a putative role in the pathophysiology of migraine headaches and may be a candidate for biomarker status. CGRP is released from neuronal fibers upon activation and induces sterile neurogenic inflammation and arterial vasodilation in the vasculature that receives trigeminal efferent innervation. The presence of CGRP in the peripheral vasculature has spurred investigations to detect and quantify this neuropeptide in human plasma using proteomic assays, such as the enzyme-linked immunosorbent assay (ELISA). However, its half-life of 6.9 min and the variability in technical details of assay protocols, which are often not fully described, have yielded inconsistent CGRP ELISA data in the literature. Here, a modified ELISA protocol for the purification and quantification of CGRP in human plasma is presented. The procedural steps involve sample collection and preparation, extraction using a polar sorbent as a means of purification, additional steps to block non-specific binding, and quantification via ELISA. Further, the protocol has been validated with spike and recovery and linearity of dilution experiments. This validated protocol can theoretically be used to quantify CGRP concentrations in the plasma of individuals not only with migraine, but also with other diseases in which CGRP may play a role.

Wprowadzenie

Calcitonin gene-related peptide (CGRP) is a 37-amino acid neuropeptide that is present in neuronal fibers with perivascular localization as well as non-neuronal tissues. The two forms of CGRP, α- and β-CGRP, share more than 90% homology and share physiologic functions; however, αCGRP is found in the central and peripheral nervous system, while βCGRP is found in the enteric nervous system1,2. Upon nociceptor activation and calcium-dependent exocytosis, CGRP is released from neurons, inducing sterile neurogenic inflammation involving arterial vasodilatation and plasma protein extravasation

Protokół

This protocol was developed using human plasma samples from consented individuals with approval from the Johns Hopkins Institutional Review Board (NA_00092491).

1. Sample collection and preparation

  1. Collect 5 mL of whole blood from the antecubital vein via standard venipuncture methods34 into a 6 mL vacutainer ethylenediaminetetraacetic acid (EDTA) collection tube.
  2. Add 0.5 mL of aprotinin (10,000 KIU/mL) competitive serine protease inhibitor to the tube after collection to block the lysis of the target peptide. Invert the tube 10 times to allow the aprotinin to adequatel....

Wyniki

There are several key steps in the protocol that should be highlighted. Firstly, aprotinin, a serine protease inhibitor, must be added to whole blood samples immediately upon collection to prevent further enzymatic degradation of CGRP. Serine proteases have been shown to play a role in CGRP metabolism, and a previous study has also used aprotinin in quantifying CGRP in humans21,35. If protease inhibitors are not used, and sample preparation takes longer than 60 m.......

Dyskusje

This article describes a validated protocol allowing for the detection and quantification of CGRP in human plasma. This protocol was synthesized after commercial CGRP ELISA kits were found to not accurately quantify this molecule. After establishing a sample preparation protocol and a valid standard curve, spike and recovery and linearity of dilution experiments showed that the percentage of recoveries were much lower than expected. Similar results were found using a different commercial CGRP ELISA kit (Table 4

Ujawnienia

The authors have no further disclosures to add.

Podziękowania

We would like to thank Robert N. Cole, Lauren R. DeVine, and Marcos Iglesias for their helpful discussions regarding this protocol. This was supported in part by funding from the American Otological Society (Fellowship Grant, PSK), the American Hearing Research Foundation (90066548/90072266, JPC), and the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research (UL1 TR003098, NSF). The publication's contents are solely the responsibility of the authors and do not necessarily represent the official view of the Johns Hopkins ICTR, NCATS, or NIH.

....

Materiały

NameCompanyCatalog NumberComments
1.7 mL Safeseal microcentrifuge tubeSorenson Bioscience, Inc.11510
99% methanolThermoFisher ScientificL13255.0F
15 mL conical centrifuge tubeFalcon14-959-49B
2 mL round bottom sterile cryovialsCRYO.S122263
4% acetic acidThermoFisher Scientific035572.K2
6.0 mL Vacutainer EDTA collection tubeBD367863
Allegra 64R benchtop centrifugeBeckman Coulter, Inc.367586
AprotininVWR76344-814
CGRP (human) ELISA kitBertin BioreagentA05481
CGRP stockBertin Bioreagent
EIA BufferBertin BioreagentA07000
Ellman's ReagentBertin BioreagentA09000_49+1
Multichannel pipettesThermoFisher Scientific4661180N
Oasis HLB 3 cc Vac CartridgesWatersWAT094226
Orbital ShakerBellco7744-01010
Precision micropipettesThermoFisher ScientificF144055MG
SpectraMax M Series Multi-Mode Microplate readerMolecular DevicesPart Number M2
TBS/Fish GelatinBioworld, from Fischer Scientific50-199-167
Ultrapure water ELISA GradeBertin BioreagentA07001
Vacufuge plus - Centrifuge ConcentratorEppendorf22820109
Wash BufferBertin BioreagentA17000

Odniesienia

  1. Russell, F. A., King, R., Smillie, S. -. J., Kodji, X., Brain, S. D. Calcitonin gene-related peptide: physiology and pathophysiology. Physiological Reviews. 94 (4), 1099-1142 (2014).
  2. Brain, S. D., Grant, A. D. Vascular....

Przedruki i uprawnienia

Zapytaj o uprawnienia na użycie tekstu lub obrazów z tego artykułu JoVE

Zapytaj o uprawnienia

Przeglądaj więcej artyków

CGRPEnzyme linked Immunosorbent AssayELISAPlasmaPurificationExtractionQuantificationMigraineBiomarker

This article has been published

Video Coming Soon

JoVE Logo

Prywatność

Warunki Korzystania

Zasady

Badania

Edukacja

O JoVE

Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone